US Buying $290M Worth Of Anti-Radiation Drugs for Use In "Nuclear Emergency"
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Source: zerohedge.com
Page 2 - Bioshield Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Bioshield Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Bioshield Act Today - Breaking & Trending Today
U.S. Buying $290M Worth of Anti-Radiation Drugs for Use in 'Nuclear Emergency'
Infowars: There's a War on for your Mind!
Source: infowars.com
GoLocalProv | U.S. Shells Out $290M to Stockpile Radiation Sickness Pills — Made by Amgen
The United States Department of Health and Human Services this week announced that it has spent $290 million to purchase drugs for use in radiological and nuclear emergencies.
Source: golocalprov.com
Aktiv Pharma Group wins contract valued at up to $220 million to supply life-saving emergency autoinjectors to the Strategic National Stockpile
Broomfield, CO (PRWEB) October 05, 2022 -- Aktiv Pharma Group (Aktiv) today announced a procurement contract award from the Biomedical Advanced Research and
Source: prweb.com
COVID-19 Vaccines and Emergency Use Authorization Challenges | Bradley Arant Boult Cummings LLP
To embed, copy and paste the code into your website or blog: With employers reopening fully and employees returning to the workplace from the pandemic, there has been a steady flow of challenges -- both legal filings and political and public opposition -- by individuals opposing mandatory requirements from employers and institutions to be vaccinated in order to return to work or school, subject to certain legal requirements under the ADA and valid religious objections. The legal challenges have centered, in large part, on the Food and Drug Administration (FDA) ability to issue “emergency ...
Source: jdsupra.com